PLUS1
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Shield Therapeutics Plc | LSE:STX | London | Ordinary Share | GB00BYV81293 | ORD 1.5P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.80 | -1.45% | 54.20 | 54.00 | 55.00 | 55.50 | 54.50 | 55.50 | 703,475 | 16:35:01 |
| Industry Sector | Turnover (m) | Profit (m) | EPS - Basic | PE Ratio | Market Cap (m) |
|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 0.7 | -9.1 | -8.0 | - | 117 |
Shield Therapeutics (STX) News Headlines
Shield Therapeutics News
| Date | Time | Source | Headline |
|---|---|---|---|
| 18/6/2021 | 15:39 | ALNC |  EXECUTIVE CHANGES: Trident Royalties picks ex-Glencore member as chair |
| 18/6/2021 | 07:00 | UKREG | Shield Therapeutics PLC Directorate Change |
| 17/6/2021 | 14:30 | UKREG | Shield Therapeutics PLC Results of 2021 Annual General Meeting |
| 15/6/2021 | 18:15 | UKREG | Shield Therapeutics PLC Grant of share options to the CEO |
| 28/5/2021 | 15:48 | ALNC | EXECUTIVE CHANGES: Mitchells & Butlers slims board following fundraise |
| 28/5/2021 | 07:00 | UKREG | Shield Therapeutics PLC Total Voting Rights |
| 21/5/2021 | 17:51 | ALNC | TRADING UPDATES: Arkle spots gold; SDCL seals USD177 million buy |
| 21/5/2021 | 07:00 | UKREG | Shield Therapeutics PLC US update |
| 18/5/2021 | 19:15 | ALNC | TRADING UPDATES: Forterra to beat outlook; Nostrum revenue falls |
| 18/5/2021 | 07:00 | RNSNON | Shield Therapeutics PLC AEGIS-H2H study results published in IBD |
1 Year Shield Therapeutics Chart |
Intraday Shield Therapeutics Chart |
